<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE config [
   <!ENTITY rarr  "...">
]>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>medizintechnik-experte.deDrug transporters – from in-vitro methods to brain penetration &#8211; medizintechnik-experte.de</title>
	<atom:link href="http://www.medizintechnik-experte.de/2012/01/03/drug-transporters-from-in-vitro-methods-to-brain-penetration-142/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.medizintechnik-experte.de</link>
	<description>Nachrichten aus der Medizintechnik</description>
	<lastBuildDate>Tue, 13 Dec 2022 14:10:42 +0000</lastBuildDate>
	<language>de-DE</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=4.7.5</generator>
		<item>
		<title>Drug transporters – from in-vitro methods to brain penetration</title>
		<link>http://www.medizintechnik-experte.de/2012/01/03/drug-transporters-from-in-vitro-methods-to-brain-penetration-142/</link>
		<comments>http://www.medizintechnik-experte.de/2012/01/03/drug-transporters-from-in-vitro-methods-to-brain-penetration-142/#respond</comments>
		<pubDate>Tue, 03 Jan 2012 16:51:31 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Allgemein]]></category>

		<guid isPermaLink="false">http://www.medizintechnik-experte.de/drug-transporters-from-in-vitro-methods-to-brain-penetration-142-142</guid>
		<description><![CDATA[New FDA safety guidelines concerning active drug transporters will be released within the coming months. Get updates on new regulatory requirements at IQPC’s 3rd International Conference on Clinically Relevant Drug Transporters, 27 – 29 February 2012...]]></description>
	<div class="pm_intro">Pressemeldung der Firma IQPC GmbH</div>			<content:encoded><![CDATA[New FDA safety guidelines concerning active drug transporters will be released within the coming months. Get updates on new regulatory requirements at IQPC’s 3rd International Conference on Clinically Relevant Drug Transporters, 27 – 29 February 2012...]]></content:encoded>
			<wfw:commentRss>http://www.medizintechnik-experte.de/2012/01/03/drug-transporters-from-in-vitro-methods-to-brain-penetration-142/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
